Skip to content

A Randomized Clinical Trial to Evaluate the Effect of Ayurvedic Nasal Drop with and without Food Preparation.

A Randomized Clinical Trial to Evaluate the Preventive Effect of Anutaila Pratimarsha Nasya with and without Badampaka in Ardhavbhedaka w.s.r to Chronic Migraine

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/031745
Enrollment
50
Registered
2021-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43- Migraine

Interventions

Intervention1: Anutaila Pratimarsha Nasya And Badampaka will be given.: Anutaila will be given 2 drops in each nostril, twice a day that is in morning and evening. ï?· Badampaka will be given in 50 gm

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients willing to participate in this trial through written informed consent. 2. Patients between 18 to 60 years of age of either sex. 3. Patients fulfilling the criteria of chronic migraine and Ardhavbhedaka. 4. Patients who are taken modern drug for headache.

Exclusion criteria

Exclusion criteria: 1. Secondary headaches caused by meningitis, tumors, encephalitis, head and neck trauma, trigeminal neuralgia, cervical spondylitis, refractive errors, sinusitis and other disorders of cranium, neck, eyes, ears, nose, sinuses, teeth etc. 2. Patients with complicated migraine like status migrainosus, hemiplegic Migraine and having any chronic debilitating disease with other neurological pathology. 3. Pregnant and lactating women 4. Patients suffering from any other major systemic disorders e.g. tuberculosis, cancer, heart disease etc 5. Lactose intolerance patients.

Design outcomes

Primary

MeasureTime frame
Symptomatic relief in headache.Timepoint: 8 week

Secondary

MeasureTime frame
withdrawal of modern drug in Ardhavbhedaka w.s.r to chronic migraine during trial.Timepoint: 8 week

Countries

India

Contacts

Public ContactDr Shashi Bala Saini

National Institute of Ayurveda,Jaipur

drsarvesh1008@gmail.com8058697177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026